Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from (used in) operating activities:
Net income (loss) from operations	$ (1,233,166)	$ 4,130,854
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Realized and unrealized gains on long-term investments	0	(3,336,295)
Gain on sale of noncontrolling interest in subsidiary	0	(778,872)
Accrued stock compensation expense	(250,000)	75,000
Gain on sale of real estate	(43,140)	(120,787)
Bad debt expense (recoveries)	11,392	(67)
Depreciation and amortization	6,267	5,307
Accrued interest income on notes receivable	0	(9,352)
Other	720	231
(Increase) decrease in:
Investment redemption receivable	3,733,795	0
Accounts receivable, net	300,350	(225,035)
Income tax benefit	(13,468)	0
Other current assets	(5,433)	12,761
Increase (decrease) in:
Accounts payable	(381)	(23,886)
Accrued expenses	(63,354)	(23,960)
Deferred revenue	19,612	5,957
Income taxes payable	(6,532)	0
Net cash flows from (used in) operating activities	2,456,662	(288,144)
Cash flows from investing activities:
Proceeds from sale of investments	0	8,458,895
Proceeds from sale of subsidiary	0	850,000
Proceeds from sale of real estate	69,603	332,000
Purchases of investments	0	(69,013)
Net cash flows from investing activities	69,603	9,571,882
Cash flows used in financing activities:
Principal payments on note payable	0	(225,633)
Net cash flows used in financing activities	0	(225,633)
Net increase in cash	2,526,265	9,058,105
Cash and cash equivalents at beginning of the period	13,487,482	341,007
Cash and cash equivalents at end of the period	16,013,747	9,399,112
Non-cash and other supplemental information:
Consulting services received in lieu of cash receipts	25,500	25,500
Issuance of common stock per equity compensation plan	0	240,000
Transfer of real estate held for investment to held for resale	0	211,213
Accrued interest receivable converted to common stock	0	45,410
Cash paid for interest	$ 0	$ 6,945